Pay in 4 interest-free payments of $6.04 Learn more
Ships within 48 hours · Estimated delivery Sep 1 - Sep 6
Mechanistic studies confirm that GLP-1 receptor activation in the gastric fundus and pylorus reduces gastric motility and delays emptying
Tirzepatides cardiovascular outcome trials are still ongoing, though early indicators suggest it may offer similar or potentially greater cardiovascular protection given its superior metabolic effects
A research-labelled product is not an authorised alternative to a prescription medicine
Novo Nordisk is developing it as part of CagriSema , a combination with semaglutide
Estimates from World Health Organization indicates that over 750 million people are living with obesity and the global market for anti-obesity medications in 2023 reached $6 billion
Most protocols begin at 2mg weekly, increasing by 2mg every four weeks until reaching the target dose
